Global Pharmaceutical Solid Dosage Contract Manufacturing Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 287368
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Services
Buy @ $3500

The Pharmaceutical Solid Dosage Contract Manufacturing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Pharmaceutical Solid Dosage Contract Manufacturing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Instant Release accounting for % of the Pharmaceutical Solid Dosage Contract Manufacturing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tablets segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Pharmaceutical Solid Dosage Contract Manufacturing include Abbott Laboratories, Catalent Pharma Solutions, Jubilant Life Sciences Limited, Alkermes, and BioPharma Solutions, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Pharmaceutical Solid Dosage Contract Manufacturing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Tablets

Capsule

Lozenge

Powder

Others

Market segment by Application, can be divided into

Instant Release

Sustained Release

Extended Release

Effervescent Tablets

Chewable Tablets

Enteric Release

Market segment by players, this report covers

Abbott Laboratories

Catalent Pharma Solutions

Jubilant Life Sciences Limited

Alkermes

BioPharma Solutions

Cytovance Biologics

DPT Laboratories

Fresenius Kabi

Halo Pharmaceutical

Lyophilization Technology

Mikart

Pillar5 Pharma

Haupt Pharma

Althea Technologies

Associates of Cape Cod

Covance

Emergent BioSolutions

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Pharmaceutical Solid Dosage Contract Manufacturing product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Pharmaceutical Solid Dosage Contract Manufacturing, with revenue, gross margin and global market share of Pharmaceutical Solid Dosage Contract Manufacturing from 2019 to 2022.

Chapter 3, the Pharmaceutical Solid Dosage Contract Manufacturing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Pharmaceutical Solid Dosage Contract Manufacturing market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Pharmaceutical Solid Dosage Contract Manufacturing research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Pharmaceutical Solid Dosage Contract Manufacturing

1.2 Classification of Pharmaceutical Solid Dosage Contract Manufacturing by Type

1.2.1 Overview: Global Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Share by Type in 2021

1.2.3 Tablets

1.2.4 Capsule

1.2.5 Lozenge

1.2.6 Powder

1.2.7 Others

1.3 Global Pharmaceutical Solid Dosage Contract Manufacturing Market by Application

1.3.1 Overview: Global Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Instant Release

1.3.3 Sustained Release

1.3.4 Extended Release

1.3.5 Effervescent Tablets

1.3.6 Chewable Tablets

1.3.7 Enteric Release

1.4 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Size & Forecast

1.5 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Forecast by Region

1.5.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Region, (2017-2022)

1.5.3 North America Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Prospect (2017-2028)

1.5.4 Europe Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Prospect (2017-2028)

1.5.6 South America Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Pharmaceutical Solid Dosage Contract Manufacturing Market Drivers

1.6.2 Pharmaceutical Solid Dosage Contract Manufacturing Market Restraints

1.6.3 Pharmaceutical Solid Dosage Contract Manufacturing Trends Analysis

2 Company Profiles

2.1 Abbott Laboratories

2.1.1 Abbott Laboratories Details

2.1.2 Abbott Laboratories Major Business

2.1.3 Abbott Laboratories Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

2.1.4 Abbott Laboratories Pharmaceutical Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Abbott Laboratories Recent Developments and Future Plans

2.2 Catalent Pharma Solutions

2.2.1 Catalent Pharma Solutions Details

2.2.2 Catalent Pharma Solutions Major Business

2.2.3 Catalent Pharma Solutions Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

2.2.4 Catalent Pharma Solutions Pharmaceutical Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Catalent Pharma Solutions Recent Developments and Future Plans

2.3 Jubilant Life Sciences Limited

2.3.1 Jubilant Life Sciences Limited Details

2.3.2 Jubilant Life Sciences Limited Major Business

2.3.3 Jubilant Life Sciences Limited Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

2.3.4 Jubilant Life Sciences Limited Pharmaceutical Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Jubilant Life Sciences Limited Recent Developments and Future Plans

2.4 Alkermes

2.4.1 Alkermes Details

2.4.2 Alkermes Major Business

2.4.3 Alkermes Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

2.4.4 Alkermes Pharmaceutical Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Alkermes Recent Developments and Future Plans

2.5 BioPharma Solutions

2.5.1 BioPharma Solutions Details

2.5.2 BioPharma Solutions Major Business

2.5.3 BioPharma Solutions Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

2.5.4 BioPharma Solutions Pharmaceutical Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 BioPharma Solutions Recent Developments and Future Plans

2.6 Cytovance Biologics

2.6.1 Cytovance Biologics Details

2.6.2 Cytovance Biologics Major Business

2.6.3 Cytovance Biologics Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

2.6.4 Cytovance Biologics Pharmaceutical Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Cytovance Biologics Recent Developments and Future Plans

2.7 DPT Laboratories

2.7.1 DPT Laboratories Details

2.7.2 DPT Laboratories Major Business

2.7.3 DPT Laboratories Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

2.7.4 DPT Laboratories Pharmaceutical Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 DPT Laboratories Recent Developments and Future Plans

2.8 Fresenius Kabi

2.8.1 Fresenius Kabi Details

2.8.2 Fresenius Kabi Major Business

2.8.3 Fresenius Kabi Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

2.8.4 Fresenius Kabi Pharmaceutical Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Fresenius Kabi Recent Developments and Future Plans

2.9 Halo Pharmaceutical

2.9.1 Halo Pharmaceutical Details

2.9.2 Halo Pharmaceutical Major Business

2.9.3 Halo Pharmaceutical Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

2.9.4 Halo Pharmaceutical Pharmaceutical Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Halo Pharmaceutical Recent Developments and Future Plans

2.10 Lyophilization Technology

2.10.1 Lyophilization Technology Details

2.10.2 Lyophilization Technology Major Business

2.10.3 Lyophilization Technology Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

2.10.4 Lyophilization Technology Pharmaceutical Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Lyophilization Technology Recent Developments and Future Plans

2.11 Mikart

2.11.1 Mikart Details

2.11.2 Mikart Major Business

2.11.3 Mikart Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

2.11.4 Mikart Pharmaceutical Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Mikart Recent Developments and Future Plans

2.12 Pillar5 Pharma

2.12.1 Pillar5 Pharma Details

2.12.2 Pillar5 Pharma Major Business

2.12.3 Pillar5 Pharma Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

2.12.4 Pillar5 Pharma Pharmaceutical Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Pillar5 Pharma Recent Developments and Future Plans

2.13 Haupt Pharma

2.13.1 Haupt Pharma Details

2.13.2 Haupt Pharma Major Business

2.13.3 Haupt Pharma Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

2.13.4 Haupt Pharma Pharmaceutical Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Haupt Pharma Recent Developments and Future Plans

2.14 Althea Technologies

2.14.1 Althea Technologies Details

2.14.2 Althea Technologies Major Business

2.14.3 Althea Technologies Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

2.14.4 Althea Technologies Pharmaceutical Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Althea Technologies Recent Developments and Future Plans

2.15 Associates of Cape Cod

2.15.1 Associates of Cape Cod Details

2.15.2 Associates of Cape Cod Major Business

2.15.3 Associates of Cape Cod Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

2.15.4 Associates of Cape Cod Pharmaceutical Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Associates of Cape Cod Recent Developments and Future Plans

2.16 Covance

2.16.1 Covance Details

2.16.2 Covance Major Business

2.16.3 Covance Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

2.16.4 Covance Pharmaceutical Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Covance Recent Developments and Future Plans

2.17 Emergent BioSolutions

2.17.1 Emergent BioSolutions Details

2.17.2 Emergent BioSolutions Major Business

2.17.3 Emergent BioSolutions Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

2.17.4 Emergent BioSolutions Pharmaceutical Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Emergent BioSolutions Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Pharmaceutical Solid Dosage Contract Manufacturing Players Market Share in 2021

3.2.2 Top 10 Pharmaceutical Solid Dosage Contract Manufacturing Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Pharmaceutical Solid Dosage Contract Manufacturing Players Head Office, Products and Services Provided

3.4 Pharmaceutical Solid Dosage Contract Manufacturing Mergers & Acquisitions

3.5 Pharmaceutical Solid Dosage Contract Manufacturing New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Market Share by Type (2017-2022)

4.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Share by Application (2017-2022)

5.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Type (2017-2028)

6.2 North America Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Application (2017-2028)

6.3 North America Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Country

6.3.1 North America Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Country (2017-2028)

6.3.2 United States Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)

6.3.3 Canada Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)

6.3.4 Mexico Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Type (2017-2028)

7.2 Europe Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Application (2017-2028)

7.3 Europe Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Country

7.3.1 Europe Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Country (2017-2028)

7.3.2 Germany Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)

7.3.3 France Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)

7.3.5 Russia Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)

7.3.6 Italy Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Type (2017-2028)

8.2 Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Application (2017-2028)

8.3 Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Region

8.3.1 Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Region (2017-2028)

8.3.2 China Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)

8.3.3 Japan Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)

8.3.4 South Korea Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)

8.3.5 India Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)

8.3.7 Australia Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Type (2017-2028)

9.2 South America Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Application (2017-2028)

9.3 South America Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Country

9.3.1 South America Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Country (2017-2028)

9.3.2 Brazil Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)

9.3.3 Argentina Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Type (2017-2028)

10.2 Middle East & Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Application (2017-2028)

10.3 Middle East & Africa Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Country

10.3.1 Middle East & Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Country (2017-2028)

10.3.2 Turkey Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)

10.3.4 UAE Pharmaceutical Solid Dosage Contract Manufacturing Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Pharmaceutical Solid Dosage Contract Manufacturing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million) by Region (2017-2022)

Table 5. Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Share by Region (2023-2028)

Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Laboratories Major Business

Table 8. Abbott Laboratories Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

Table 9. Abbott Laboratories Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Catalent Pharma Solutions Corporate Information, Head Office, and Major Competitors

Table 11. Catalent Pharma Solutions Major Business

Table 12. Catalent Pharma Solutions Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

Table 13. Catalent Pharma Solutions Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Jubilant Life Sciences Limited Corporate Information, Head Office, and Major Competitors

Table 15. Jubilant Life Sciences Limited Major Business

Table 16. Jubilant Life Sciences Limited Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

Table 17. Jubilant Life Sciences Limited Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Alkermes Corporate Information, Head Office, and Major Competitors

Table 19. Alkermes Major Business

Table 20. Alkermes Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

Table 21. Alkermes Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. BioPharma Solutions Corporate Information, Head Office, and Major Competitors

Table 23. BioPharma Solutions Major Business

Table 24. BioPharma Solutions Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

Table 25. BioPharma Solutions Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Cytovance Biologics Corporate Information, Head Office, and Major Competitors

Table 27. Cytovance Biologics Major Business

Table 28. Cytovance Biologics Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

Table 29. Cytovance Biologics Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. DPT Laboratories Corporate Information, Head Office, and Major Competitors

Table 31. DPT Laboratories Major Business

Table 32. DPT Laboratories Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

Table 33. DPT Laboratories Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Fresenius Kabi Corporate Information, Head Office, and Major Competitors

Table 35. Fresenius Kabi Major Business

Table 36. Fresenius Kabi Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

Table 37. Fresenius Kabi Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Halo Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 39. Halo Pharmaceutical Major Business

Table 40. Halo Pharmaceutical Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

Table 41. Halo Pharmaceutical Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Lyophilization Technology Corporate Information, Head Office, and Major Competitors

Table 43. Lyophilization Technology Major Business

Table 44. Lyophilization Technology Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

Table 45. Lyophilization Technology Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Mikart Corporate Information, Head Office, and Major Competitors

Table 47. Mikart Major Business

Table 48. Mikart Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

Table 49. Mikart Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Pillar5 Pharma Corporate Information, Head Office, and Major Competitors

Table 51. Pillar5 Pharma Major Business

Table 52. Pillar5 Pharma Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

Table 53. Pillar5 Pharma Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Haupt Pharma Corporate Information, Head Office, and Major Competitors

Table 55. Haupt Pharma Major Business

Table 56. Haupt Pharma Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

Table 57. Haupt Pharma Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Althea Technologies Corporate Information, Head Office, and Major Competitors

Table 59. Althea Technologies Major Business

Table 60. Althea Technologies Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

Table 61. Althea Technologies Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Associates of Cape Cod Corporate Information, Head Office, and Major Competitors

Table 63. Associates of Cape Cod Major Business

Table 64. Associates of Cape Cod Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

Table 65. Associates of Cape Cod Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Covance Corporate Information, Head Office, and Major Competitors

Table 67. Covance Major Business

Table 68. Covance Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

Table 69. Covance Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Emergent BioSolutions Corporate Information, Head Office, and Major Competitors

Table 71. Emergent BioSolutions Major Business

Table 72. Emergent BioSolutions Pharmaceutical Solid Dosage Contract Manufacturing Product and Solutions

Table 73. Emergent BioSolutions Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 75. Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 76. Breakdown of Pharmaceutical Solid Dosage Contract Manufacturing by Company Type (Tier 1, Tier 2 and Tier 3)

Table 77. Pharmaceutical Solid Dosage Contract Manufacturing Players Head Office, Products and Services Provided

Table 78. Pharmaceutical Solid Dosage Contract Manufacturing Mergers & Acquisitions in the Past Five Years

Table 79. Pharmaceutical Solid Dosage Contract Manufacturing New Entrants and Expansion Plans

Table 80. Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million) by Type (2017-2022)

Table 81. Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue Share by Type (2017-2022)

Table 82. Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue Forecast by Type (2023-2028)

Table 83. Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Application (2017-2022)

Table 84. Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue Forecast by Application (2023-2028)

Table 85. North America Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Type (2017-2022) & (USD Million)

Table 86. North America Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Type (2023-2028) & (USD Million)

Table 87. North America Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Application (2017-2022) & (USD Million)

Table 88. North America Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Application (2023-2028) & (USD Million)

Table 89. North America Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Country (2017-2022) & (USD Million)

Table 90. North America Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Country (2023-2028) & (USD Million)

Table 91. Europe Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Type (2017-2022) & (USD Million)

Table 92. Europe Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Type (2023-2028) & (USD Million)

Table 93. Europe Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Application (2017-2022) & (USD Million)

Table 94. Europe Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Application (2023-2028) & (USD Million)

Table 95. Europe Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Country (2017-2022) & (USD Million)

Table 96. Europe Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Country (2023-2028) & (USD Million)

Table 97. Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Type (2017-2022) & (USD Million)

Table 98. Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Type (2023-2028) & (USD Million)

Table 99. Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Application (2017-2022) & (USD Million)

Table 100. Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Application (2023-2028) & (USD Million)

Table 101. Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Region (2017-2022) & (USD Million)

Table 102. Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Region (2023-2028) & (USD Million)

Table 103. South America Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Type (2017-2022) & (USD Million)

Table 104. South America Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Type (2023-2028) & (USD Million)

Table 105. South America Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Application (2017-2022) & (USD Million)

Table 106. South America Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Application (2023-2028) & (USD Million)

Table 107. South America Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Country (2017-2022) & (USD Million)

Table 108. South America Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Country (2023-2028) & (USD Million)

Table 109. Middle East & Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Type (2017-2022) & (USD Million)

Table 110. Middle East & Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Type (2023-2028) & (USD Million)

Table 111. Middle East & Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Application (2017-2022) & (USD Million)

Table 112. Middle East & Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Application (2023-2028) & (USD Million)

Table 113. Middle East & Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Country (2017-2022) & (USD Million)

Table 114. Middle East & Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Pharmaceutical Solid Dosage Contract Manufacturing Picture

Figure 2. Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Share by Type in 2021

Figure 3. Tablets

Figure 4. Capsule

Figure 5. Lozenge

Figure 6. Powder

Figure 7. Others

Figure 8. Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Share by Application in 2021

Figure 9. Instant Release Picture

Figure 10. Sustained Release Picture

Figure 11. Extended Release Picture

Figure 12. Effervescent Tablets Picture

Figure 13. Chewable Tablets Picture

Figure 14. Enteric Release Picture

Figure 15. Global Pharmaceutical Solid Dosage Contract Manufacturing Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 16. Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Forecast (2017-2028) & (USD Million)

Figure 17. Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Share by Region (2017-2028)

Figure 18. Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Share by Region in 2021

Figure 19. North America Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Europe Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. South America Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 23. Middle East and Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 24. Pharmaceutical Solid Dosage Contract Manufacturing Market Drivers

Figure 25. Pharmaceutical Solid Dosage Contract Manufacturing Market Restraints

Figure 26. Pharmaceutical Solid Dosage Contract Manufacturing Market Trends

Figure 27. Abbott Laboratories Recent Developments and Future Plans

Figure 28. Catalent Pharma Solutions Recent Developments and Future Plans

Figure 29. Jubilant Life Sciences Limited Recent Developments and Future Plans

Figure 30. Alkermes Recent Developments and Future Plans

Figure 31. BioPharma Solutions Recent Developments and Future Plans

Figure 32. Cytovance Biologics Recent Developments and Future Plans

Figure 33. DPT Laboratories Recent Developments and Future Plans

Figure 34. Fresenius Kabi Recent Developments and Future Plans

Figure 35. Halo Pharmaceutical Recent Developments and Future Plans

Figure 36. Lyophilization Technology Recent Developments and Future Plans

Figure 37. Mikart Recent Developments and Future Plans

Figure 38. Pillar5 Pharma Recent Developments and Future Plans

Figure 39. Haupt Pharma Recent Developments and Future Plans

Figure 40. Althea Technologies Recent Developments and Future Plans

Figure 41. Associates of Cape Cod Recent Developments and Future Plans

Figure 42. Covance Recent Developments and Future Plans

Figure 43. Emergent BioSolutions Recent Developments and Future Plans

Figure 44. Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue Share by Players in 2021

Figure 45. Pharmaceutical Solid Dosage Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 46. Global Top 3 Players Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Share in 2021

Figure 47. Global Top 10 Players Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Share in 2021

Figure 48. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 49. Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue Share by Type in 2021

Figure 50. Global Pharmaceutical Solid Dosage Contract Manufacturing Market Share Forecast by Type (2023-2028)

Figure 51. Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue Share by Application in 2021

Figure 52. Global Pharmaceutical Solid Dosage Contract Manufacturing Market Share Forecast by Application (2023-2028)

Figure 53. North America Pharmaceutical Solid Dosage Contract Manufacturing Sales Market Share by Type (2017-2028)

Figure 54. North America Pharmaceutical Solid Dosage Contract Manufacturing Sales Market Share by Application (2017-2028)

Figure 55. North America Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Share by Country (2017-2028)

Figure 56. United States Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Canada Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Mexico Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Europe Pharmaceutical Solid Dosage Contract Manufacturing Sales Market Share by Type (2017-2028)

Figure 60. Europe Pharmaceutical Solid Dosage Contract Manufacturing Sales Market Share by Application (2017-2028)

Figure 61. Europe Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Share by Country (2017-2028)

Figure 62. Germany Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. France Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. United Kingdom Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Russia Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Italy Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Sales Market Share by Type (2017-2028)

Figure 68. Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Sales Market Share by Application (2017-2028)

Figure 69. Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Share by Region (2017-2028)

Figure 70. China Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Japan Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. South Korea Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. India Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Southeast Asia Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Australia Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. South America Pharmaceutical Solid Dosage Contract Manufacturing Sales Market Share by Type (2017-2028)

Figure 77. South America Pharmaceutical Solid Dosage Contract Manufacturing Sales Market Share by Application (2017-2028)

Figure 78. South America Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Share by Country (2017-2028)

Figure 79. Brazil Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Argentina Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Middle East and Africa Pharmaceutical Solid Dosage Contract Manufacturing Sales Market Share by Type (2017-2028)

Figure 82. Middle East and Africa Pharmaceutical Solid Dosage Contract Manufacturing Sales Market Share by Application (2017-2028)

Figure 83. Middle East and Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Share by Country (2017-2028)

Figure 84. Turkey Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 85. Saudi Arabia Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 86. UAE Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 87. Methodology

Figure 88. Research Process and Data Source